Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Geriatr Psychiatry. 2017 Apr 25;25(10):1150–1159. doi: 10.1016/j.jagp.2017.04.013

Table 1. Characteristics of Subjects across all Studies at Baseline.

Subjects are classified as Alzheimer’s Disease (AD), mild cognitive impairment (MCI), or normal (NL) at the time of study entry. HS=high school.

AD MCI NL
N African
American
(N=232)
White
(N=3304)
P Value N African
American
(N=50)
White
(N=1147)
P Value N African
American
(N=94)
White
(N=729)
P Value
Age, years 3525 74.75+/− 8.49 75.40+/− 8.43 F1,3523=1.45 p=0.228 1197 73.42+/− 8.25 73.92+/− 7.23 F1,1195=0 p=0.953 823 76.21+/− 5.91 76.62+/− 6.26 F1,821=0.3 p=0.587
Education, less than HS 3536 34% (78) 14% (454) χ22=73.8 p<0.001 1197 22% (11) 8% (88) χ22=13.9 p<0.001 823 18% (17) 4% (32) χ22=37.3 p<0.001
  HS graduate 47% (109) 51% (1680) 40% (20) 39% (452) 48% (45) 37% (273)
  College graduate 19% (45) 35% (1170) 38% (19) 53% (607) 34% (32) 58% (424)
Ethnicity, Hispanic 3536 1% (3) 2% (73) χ22=0.87 p=0.648 1197 0% (0) 1% (8) χ22=0.53 p=0.768 823 0% (0) 0% (1) χ22=0.52 0.772
  Not Hispanic 98% (228) 97% (3216) 100% (50) 99% (1135) 100% (94) 99% (725)
Unknown 0% (1) 0% (15) 0% (0) 0% (4) 0% (0) 0% (3)
Marital Status, Married 3536 45% (105) 71% (2353) χ42=83.1 p<0.001 1196 42% (21) 78% (894) χ32=39.3 p<0.001 823 32% (30) 63% (456) χ42=41.3 p<0.001
  Widowed 41% (94) 23% (751) 30% (15) 14% (161) 45% (42) 23% (169)
  Divorced 12% (28) 4% (128) 22% (11) 6% (65) 16% (15) 9% (66)
  Never married 2% (5) 2% (67) 6% (3) 2% (26) 5% (5) 5% (37)
Unknown 0% (0) 0% (5) 0% (0) 0% (0) 2% (2) 0% (1)
Sex, female 3536 71% (165) 58% (1902) χ12=16.4 p<0.001 1197 62% (31) 42% (481) χ12=7.88 p=0.005 823 77% (72) 56% (411) χ12=14 p<0.001
placebo Treatment in Original Study, placebo 3361 44% (93) 48% (1521) χ12=16.4 p=0.263 1167 77% (37) 61% (677) χ12=5.33 p=0.021 811 100% (93) 100% (718) ---
Number of Organ Systems Affected 3536 5.09+/− 3.15 5.77+/− 3.00 F1,3534=16.5 p<0.001 1197 5.66+/− 2.96 5.86+/− 2.67 F1,1195=0.61 p=0.436 823 5.56+/− 2.72 6.24+/− 2.61 F1,821=5.33 p=0.021
ADAS-cog, baseline 2578 26.4+/− 11.7 25.8+/− 10.9 F1,2576=0.63 p=0.428 943 10.10+/− 3.59 11.36+/− 4.39 F1,941=1.33 p=0.249 245 6.89+/− 3.40 5.91+/− 2.85 F1,243=1.33 p=0.25
  Month 6 2145 27.6+/− 11.8 27.0+/− 11.6 F1,2143=0.55 p=0.459 817 9.19+/− 3.79 11.30+/− 5.34 F1,815=3.07 p=0.08 148 6.81+/− 3.46 5.88+/− 2.80 F1,146=0.61 p=0.436
  Month 12 1851 28.1+/− 12.5 28.7+/− 12.4 F1,1849=0 p=0.963 763 9.43+/− 4.55 11.91+/− 5.99 F1,761=3.02 p=0.083 141 5.76+/− 2.95 5.68+/− 2.87 F1,139=0.01 p=0.928
  Month 18 1150 29.2+/− 13.5 30.6+/− 13.2 F1,1148=0.51 p=0.475 683 9.17+/− 3.21 12.63+/− 6.82 F1,681=4.37 p=0.037 ---* ---* ---* ---*
  Month 24 278 38.9+/− 11.8 36.1+/− 14.1 F1,276=0.76 p=0.383 642 10.87+/− 4.74 12.99+/− 7.16 F1,640=1.21 p=0.271 134 8.20+/− 5.26 5.67+/− 3.03 F1,132=0.95 p=0.331

Statistical tests are shown with the degrees of freedom in subscripts.

*

Studies did not collect information on this subgroup at this time point.